... in all postinjection BCVAs of the DEX group, there was no significant difference in BCVA values of the PSTA group at 3 and 6 months after injection (Table  2 ; Fig.  1 ). Posterior subtenon triamcinolone Dexamethasone implant Diabetic macular edema Pars plana vitrectomy Diabetes...

... eyes having received multiple DEXi). Diabetic macular oedema Persistent Resistant Anti-VEGF Ranibizumab Aflibercept Dexamethasone implant The pathophysiology of diabetic macular oedema (DME) is complex as it implicates the release of pro-angiogenic factors such as vascular...

..., instructions or products referred to in the content or advertisements. Diabetic macular edema DME Type 2 diabetes Dexamethasone implant DEX-I Intravitreal treatment Real-life experience Diabetic retinopathy (DR) is a primary microvascular complication of type 1 and 2 diabetes. Over one...

...Ozgur Yalcinbayir; Enver Caliskan; Gamze Ucan Gunduz; Oner Gelisken; Berkant Kaderli; Ahmet Ali Yucel Purpose: Investigation of the efficacy of intravitreal dexamethasone implants (0.7 mg) in patients with Behçet disease (BD) who had cystoid macular edema (CME) despite immunomodulatory treatment...

...Laura Hernández-Bel; Enrique Cervera-Taulet; Catalina Navarro-Palop; Verónica Castro-Navarro; Cecilia Chiarri-Toumit; Javier Montero-Hernández Objective: The aim of this paper is to compare intravitreous aflibercept versus dexamethasone implant followed by aflibercept (sequential treatment group...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Macular edema Retinal vein occlusion Dexamethasone implant Early treatment Retinal vein occlusion...

...% of patients ( n = 88/500) still needed further high-frequency treatment defined as >7 injections per year [ 7 ], indicating that some patients may be refractory to anti-VEGF treatment. Dexamethasone implant Diabetic macular oedema Optical coherence tomography Photoreceptor integrity...

...Lars-Olof Hattenbach; Christina Springer-Wanner; Hans Hoerauf; Josep Callizo; Stephanie Jungmann; Thomas Brauns; Gergana Fulle; Sebastian Eichel; Michael Janusz Koss; Claudia Kuhli-Hattenbach Purpose: To evaluate the efficacy of intravitreal dexamethasone implant for the treatment of postoperative...

..., Mohammed Q, Ross AH, Barker C, Fonollosa A, Artaraz J, Pelegrin L, Adan A, Lee RW, Dick AD, Sallam A: Multicenter Study of Intravitreal Dexamethasone Implant in Noninfectious Uveitis: Indications, Outcomes, and Reinjection Frequency. Am J Ophthalmol 2014;158:1136-1145.e5. 11. Hunter RS, Lobo AM...

..., instructions or products referred to in the content or advertisements. Diabetic macular edema Dexamethasone implant Photocoagulation Diabetic retinopathy and diabetic macular edema (DME), which involves retinal thickening in the area of the macula, are leading causes of visual impairment...

... < 0.001) but vanished by week 24. Intraocular pressure reached ≥35 mm Hg in 3 eyes and was significantly more frequent in intermediate uveitis compared to posterior uveitis (p < 0.016). Conclusions: The dexamethasone implant is effective in controlling intraocular posterior segment inflammation...

...Sylvia Nghiem-Buffet; Franck Fajnkuchen; Marc Buffet; Sandrine Ayrault; Anna Le Gloahec-Lorcy; Typhaine Grenet; Corinne Delahaye-Mazza; Gabriel Quentel; Salomon Y. Cohen Purpose: To investigate the outcome of intravitreal ranibizumab and/or dexamethasone implant treatment for treatment of macular...

...Lea Querques; Giuseppe Querques; Rosangela Lattanzio; Silvia Rita Gigante; Claudia Del Turco; Giulia Corradetti; Maria Lucia Cascavilla; Francesco Bandello Purpose: To evaluate the effects of repeated intravitreal dexamethasone implant (IDI) (Ozurdex®) in eyes with macular edema (ME) due to retinal...